NB
WST icon

Northwest Bancshares’s West Pharmaceutical WST Stock Holding History

Northwest Bancshares’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$406K Sell
1,130
-114
-9% -$34.9K 0.07% 130
2026
Q1 		$312K Sell
1,244
-86
-6% -$21.4K 0.06% 138
2025
Q4 		$366K Sell
1,330
-160
-11% -$43.8K 0.07% 128
2025
Q3 		$391K Sell
1,490
-260
-15% -$63.2K 0.06% 137
2025
Q2 		$383K Sell
1,750
-474
-21% -$101K 0.07% 140
2025
Q1 		$498K Sell
2,224
-2,075
-48% -$572K 0.09% 117
2024
Q4 		$1.41M Sell
4,299
-6,054
-58% -$1.91M 0.26% 66
2024
Q3 		$3.11M Sell
10,353
-8,246
-44% -$2.53M 0.53% 47
2024
Q2 		$6.13M Buy
18,599
+2,077
+13% +$734K 1.04% 27
2024
Q1 		$6.54M Sell
16,522
-60
-0.4% -$22.2K 1.03% 35
2023
Q4 		$5.84M Buy
16,582
+1,195
+8% +$423K 1.06% 31
2023
Q3 		$5.77M Sell
15,387
-1,485
-9% -$574K 1.11% 24
2023
Q2 		$6.45M Buy
16,872
+6,517
+63% +$2.33M 1.17% 20
2023
Q1 		$3.59M Buy
+10,355
New +$3.03M 0.69% 46

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Northwest Bancshares's WST Position: Q2 2026 in Review

Northwest Bancshares reduced its West Pharmaceutical (WST) stake by 9.2% in Q2 2026, selling an estimated $34.9K and leaving 1,130 shares worth $406K. The position accounts for 0.07% of the portfolio, ranked #130.

Northwest Bancshares first reported a position in WST in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.54M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Northwest Bancshares held 1,130 shares of West Pharmaceutical worth $406K as of Q2 2026.
  • Northwest Bancshares sold 114 West Pharmaceutical shares in Q2 2026, an estimated $34.9K.
  • West Pharmaceutical made up 0.07% of Northwest Bancshares's portfolio in Q2 2026, its #130 holding.
  • Northwest Bancshares first reported a position in West Pharmaceutical in Q1 2023 and has held it in 14 quarters since.
  • Northwest Bancshares's West Pharmaceutical position peaked at $6.54M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Northwest Bancshares's 13F filing for Q2 2026, filed 14 Aug 2026.